Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Genalyte Raises $36M in Funding

Genalyte Raises $36M in Funding

Nov 21, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Genalyte said today that it has raised an additional $36 million in a financing round led by investors Khosla Ventures and Redmile Group.

San Diego-based Genalyte will use the funds to further refine its Maverick Detection System, a photonic microring sensor-based platform that the company is developing for rapid blood testing in outpatient settings like doctors' offices.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

German Shepherd's Own Sequence

A German shepherd called Nala has had her genome sequenced.

And Now Serology Tests

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Young at Brain

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

Science Paper Examines Factors to Identify Metastatic Prostate Cancer Responsive to Checkpoint Inhibitors

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

May
06
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In Molecular Diagnostics

  1. FDA Releases New EUA Guidance for MDx Labs Offering SARS-CoV-2 Testing

  2. Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

  3. Becton Dickinson, BioGX Get FDA Emergency Use Authorization for Rapid SARS-CoV-2 Test

  4. Siemens Healthineers Developing Molecular Kit for Coronavirus Detection

  5. Bosch Healthcare Solutions, Randox Laboratories Develop Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.